Per Norlén

Orexin loss in Huntington's disease

Åsa Petersén, Joana Gil‐Mohapel, Marion L. C. Maat–Schieman et al. · Human Molecular Genetics · 2004 · 268 citations

Dramatic Atrophy, Orexin Neurons, Orexin Loss +11

Ghrelin stimulates gastric emptying but is without effect on acid secretion and gastric endocrine cells

Charlotta Dornonville de la Cour, Erik Lindström, Per Norlén et al. · Regulatory Peptides · 2004 · 168 citations

Nutrition, Gastric Endocrine Cells, Endocrine Mechanism +9

Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease

Maria Björkqvist, Åsa Petersén, Karl Bacos et al. · Human Molecular Genetics · 2006 · 140 citations · Full text

Clinical Symptoms, Intermediate Pituitary Lobe, Glucocorticoid +16

First‐in‐human study with intratumoral administration of a CD40 agonistic antibody, ADC‐1013, in advanced solid malignancies

Sandra Irenaeus, Dorte Nielsen, Peter Ellmark et al. · International Journal of Cancer · 2019 · 121 citations

Intratumoral Administration, Adverse Events, Tumor Immunology +15

The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation

Anne Månsson Kvarnhammar, Niina Veitonmäki, Karin Hägerbrand et al. · Journal for ImmunoTherapy of Cancer · 2019 · 110 citations · Full text